Liver Diseases: Clinical Trials

13,225 trials for Liver Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6520 completed, 2700 unknown, 1426 recruiting, 917 terminated. 2940 Phase 2, 2843 Not applicable, 1912 Phase 1, 1428 Phase 3, 1107 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22940Completed 1450, Unknown 454, Terminated 337, Recruiting 306, Not yet recruiting 135, Withdrawn 131, Active not recruiting 117, Enrolling by invitation 5, Suspended 5
Not applicable2843Completed 1266, Unknown 706, Recruiting 333, Not yet recruiting 164, Terminated 150, Active not recruiting 100, Withdrawn 94, Enrolling by invitation 24, Suspended 6
Phase 11912Completed 1129, Unknown 215, Recruiting 191, Terminated 181, Withdrawn 70, Active not recruiting 65, Not yet recruiting 51, Suspended 7, Enrolling by invitation 3
Phase 31428Completed 835, Unknown 231, Terminated 113, Recruiting 97, Withdrawn 52, Active not recruiting 51, Not yet recruiting 40, Enrolling by invitation 5, Suspended 4
Phase 41107Completed 588, Unknown 298, Terminated 74, Recruiting 48, Withdrawn 47, Not yet recruiting 27, Active not recruiting 19, Enrolling by invitation 5, Suspended 1
Early Phase 1129Completed 49, Unknown 29, Recruiting 14, Not yet recruiting 13, Active not recruiting 9, Terminated 7, Withdrawn 7, Suspended 1

Follow Liver Diseases: new trials by email Literature Review of Liver Diseases trials Research Report on Liver Diseases

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
Integrated care - Opioid Use Disorder, HIV
Not applicableNot yet recruitingVA Office of Research and Development602028-04-032026-04-24
National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Evaluating Mesenchymal Stem-Cell (MSC) Therapy in Non-viral Acute on Chronic Liver Failure (ACLF) Patients - Phase-III Trial
Umbilical cord Mesenchymal stem cell, Steroid, Standard Medical Treatment - Acute-On-Chronic Liver Failure
Phase 3Not yet recruitingInstitute of Liver and Biliary Sciences, India1002028-01-012025-08-17
The Effects of Glucagon on Hepatic Metabolism in People With Type 2 Diabetes After Caloric Restriction
Caloric Restriction, Hyperglycemic clamp - Type2diabetes
Phase 2Not yet recruitingAdrian Vella202027-12-152026-10-28
Liver Steatosis in Pediatric CD Patients
Gluten-free diet - Celiac Disease in Children, Non-Alcoholic Fatty Liver Disease
RecruitingUniversity of Palermo912027-11-012026-05-01
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
Shuganhuazhuo Formula, Targeted therapy, Immunotherapy - HCC - Hepatocellular Carcinoma, Chinese Herbal Medicine
Phase 2Not yet recruitingXiang-Qian1202027-09-012026-08-27
Phase III Clinical Trial of Hepalatide in Patients With Chronic Hepatitis D
Hepalatide 2.1mg, Placebo of Hepalatide - Hepatitis D, Chronic
Phase 3Not yet recruitingShanghai HEP Pharmaceutical Co., Ltd.1502027-06-012026-10-28
SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease
Empagliflozin 10 MG, Placebo Oral Tablet - Non-Alcoholic Fatty Liver Disease, NAFLD
Phase 2Not yet recruitingJustin Ryder402027-05-012026-01-20
STRIVES: Status-Neutral TeleHealth Concierge Intervention for Unhoused People Who Use Drugs Via Engagement Through Street Medicine
Standard of Care (Patient Navigation to Off-Site Clinic), Status-Neutral Telehealth Concierge (SN-THR) - HIV, Substance Use Disorder (SUD)
Not applicableNot yet recruitingUniversity of Miami2002027-05-012026-11-12
Liver Transplantation for Non-Resectable Colorectal Liver Metastases Without Local Treatment Options
Liver transplantation - Colorectal Neoplasms, Liver Neoplasms
Not applicableNot yet recruitingCharite University, Berlin, Germany2602027-04-012026-09-10
Estimating The Rate Of Complete Ablation (A0) With The Use Of Biomechanical Deformable Image Registration
RayAblation - Liver Tumors
Not applicableNot yet recruitingM.D. Anderson Cancer Center2002027-04-012026-10-16
A Clinical Study Evaluating the Safety and Efficacy of Ivonescimab as Second-line Treatment in Patients With Advanced Hepatocellular Carcinoma
Ivonescimab - Hepatocellular Carcinoma (HCC), HCC - Hepatocellular Carcinoma
Phase 2Not yet recruitingMedSIR442027-03-012026-11-04
Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary Complications
Autologous adipose derived mesenchymal stromal cells (AMSC) - Liver Transplant; Complications, Liver Diseases
Phase 1Not yet recruitingMayo Clinic202027-02-012026-04-06
Managing Hepatitis B (Hep. B) and Human Papilloma Virus (HPV) Related Cancers and Mental Health.
Gardasil 9 vaccine, Hepatitis B Virus Vaccine(HBV), Cognitive Behavioral Therapy - Hepatitis B, Human Papilloma Virus
Phase 4Not yet recruitingEunice Dube21402027-01-302026-07-30
Ulonivirine (MK-8507) in Participants With Mild or Moderate Hepatic Impairment (MK-8507-014)
Ulonivirine - Hepatic Insufficiency
Phase 1Not yet recruitingMerck Sharp & Dohme LLC222027-01-222026-07-16
Combating Related Epidemics in HCV
Cepheid GeneXpert HCV Test, INSTI HIV - 1/2 Antibody, bioLytical Laboratories iStatis Hepatitis B Surface Antigen Test - HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV)
Phase 4Not yet recruitingDuke University12802027-01-202026-11-18
A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial)
AVIHepC1, Normal Saline - Hepatitis C
Phase 1Not yet recruitingUniversity of Alberta272027-01-152026-09-25
Liver Micro Flow - MRI
Novel MRI Software, Ensure Plus Nutrition Shake - Liver Diseases
Not yet recruitingUniversity of Wisconsin, Madison1102027-01-152026-09-29
Blood Flow Restriction Training After TIPS Placement in Liver Cirrhosis
Blood-flow restriction training (BFRT) - Liver Cirrhosis, TIPS Insertion
Not applicableNot yet recruitingGerman Diabetes Center302027-01-022026-11-13
Human Models of Selective Insulin Resistance: Pancreatic Clamp
Insulin human, Octreotide Acetate, Glucagon - Insulin Resistance, Hyperinsulinemia
Phase 1Not yet recruitingColumbia University362027-01-012026-02-06
NK521 in the Treatment of Advanced Solid Tumors
NK521 Cell Injection - Hepatocellular Carcinoma (HCC), Ovarian Cancer
Early Phase 1Not yet recruitingBase Therapeutics (Shanghai) Co., Ltd.182027-01-012026-09-30

Showing 20 of 13225. Sign in to see all of them.

Narrower conditions

Carcinoma, Hepatocellular (3390)  ·  Hepatitis C (1722)  ·  Non-alcoholic Fatty Liver Disease (1602)  ·  Liver Neoplasms (1296)  ·  Liver Cirrhosis (1273)  ·  Hepatitis B (1007)  ·  Hepatitis C, Chronic (907)  ·  Hepatitis B, Chronic (869)  ·  Fibrosis (679)  ·  Fatty Liver (600)  ·  Hypertension, Portal (365)  ·  Obesity (322)  ·  Hepatitis (321)  ·  Pancreatic Neoplasms (284)

Broader conditions

Digestive System Diseases (13149)  ·  Pathological Conditions, Signs and Symptoms (5045)  ·  Pathologic Processes (4562)  ·  Infections (4301)  ·  Neoplasms by Site (4208)  ·  Virus Diseases (4168)  ·  Digestive System Neoplasms (4163)  ·  Hepatitis (4126)  ·  Neoplasms (4046)  ·  Hepatitis, Viral, Human (4027)  ·  Blood-Borne Infections (3974)  ·  Communicable Diseases (3961)  ·  Neoplasms by Histologic Type (3603)  ·  Neoplasms, Glandular and Epithelial (3515)

Interventions

Ribavirin (673)  ·  peginterferon alfa-2a (426)  ·  Sorafenib (243)  ·  entecavir (206)  ·  Tenofovir (195)  ·  Sofosbuvir (183)  ·  peginterferon alfa-2b (182)  ·  lenvatinib (161)  ·  Bevacizumab (155)  ·  Blood Specimen Collection (106)  ·  Nivolumab (102)  ·  daclatasvir (101)  ·  atezolizumab (89)  ·  Radiosurgery (86)  ·  pembrolizumab (84)

Sponsors

GlaxoSmithKline (223)  ·  Merck Sharp & Dohme LLC (213)  ·  Gilead Sciences (201)  ·  Sun Yat-sen University (201)  ·  Bristol-Myers Squibb (164)  ·  Hoffmann-La Roche (164)  ·  Institute of Liver and Biliary Sciences, India (149)  ·  Assiut University (136)  ·  National Taiwan University Hospital (123)  ·  National Cancer Institute (NCI) (102)  ·  AbbVie (101)  ·  Shanghai Zhongshan Hospital (101)  ·  Assistance Publique - Hôpitaux de Paris (98)  ·  Seoul National University Hospital (93)  ·  National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (84)

Countries

United States (3786)  ·  China (2543)  ·  France (1027)  ·  Germany (780)  ·  United Kingdom (739)  ·  Canada (730)  ·  South Korea (730)  ·  Italy (692)  ·  Spain (684)  ·  Taiwan (634)  ·  Australia (453)  ·  Belgium (452)  ·  India (349)  ·  Egypt (341)  ·  Hong Kong (313)

Top investigators

Ming Shi, MD (21)

Results publications

PMID 37467180, PMID 30739368, PMID 30977945, PMID 12049862, PMID 30012435, PMID 30923816, PMID 28193518, PMID 29461687, PMID 31568620, PMID 11981766, PMID 19192962, PMID 28427875, PMID 30529905, PMID 36318027, PMID 12540794, PMID 18650514, PMID 29377566, PMID 29404492, PMID 29628281, PMID 40434633, PMID 19052126, PMID 19095497, PMID 23607594, PMID 25445400, PMID 26047908, PMID 28404091, PMID 28404092, PMID 30868245, PMID 32402160, PMID 32710245, PMID 34143971, PMID 34256305, PMID 36852452, PMID 37183883, PMID 37786277, PMID 41586499, PMID 12091661, PMID 21374666, PMID 24209977, PMID 24915612, PMID 25040192, PMID 25543678, PMID 25583164, PMID 26575258, PMID 26683763, PMID 26707365, PMID 27847279, PMID 27932229, PMID 29405329, PMID 29433850

NIH funding

2016 (63), 2014 (58), 2015 (56), 2019 (51), 2023 (43), 2009 (38), 2017 (36), 2018 (31), 2025 (24), 2008 (20), 2004 (13), P30CA016672 (12), 2005 (11), P30CA060553 (10), P30CA015083 (8)